Cancer Genetics, Inc. Made Headway
Wed, Nov 20, 2019 at 05:30 PM
Cancer Genetics, Inc. (CGIX:NASDAQ) rocketted today at $4.81, representing a gain of 131.3%. On Tue 19 Nov 19, CGIX:NASDAQ touched a New 2-Week Low of $2.08. The stock appeared on our News Catalysts scanner on Wed 20 Nov 19 at 01:09 PM. From Wed 30 Oct 19, the stock recorded 28.57% Up Days and 40.00% Green Days
About Cancer Genetics, Inc. (CGIX:NASDAQ)
Cancer Genetics Inc is an early-stage diagnostics company which develops, commercializes and provides molecular- and biomarker-based tests and services that enable physicians to personalize the clinical management of each individual patient.
Top 10 Gainers:
- Cancer Genetics, Inc. (CGIX:NASDAQ), 131.25%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 105.56%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 67.59%
- Aravive, Inc. (ARAV:NASDAQ), 48.08%
- Surface Oncology, Inc. (SURF:NASDAQ), 38.19%
- Cellectar Biosciences, Inc. (CLRB:NASDAQ), 33.05%
- Amira Nature Foods Ltd. (ANFI:NYSE), 29.89%
- Kiniksa Pharmaceuticals, Ltd. (KNSA:NASDAQ), 28.67%
- Zion Oil & Gas, Inc. (ZN:NASDAQ), 25.21%
- NeuBase Therapeutics, Inc. (NBSE:NASDAQ), 25.15%